For example, upon glutaminase (GLS) inhibition in pancreatic ductal adenocarcinoma (PDAC) cells, the upregulation of pyruvate carboxylase (PC), activation of lipid biosynthetic pathways, and alternative pathways involved in glutamate production allowed cells to adapt and regain proliferation [53]. Here, GLS is linked to pancreatic ductal adenocarcinoma.